Bank of America’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-37
| Closed | -$107 | – | 6832 |
|
|
2025
Q4 | $107 | Hold |
37
| – | – | ﹤0.01% | 6808 |
|
|
2025
Q3 | $381 | Buy |
37
+4
| +12% | +$35 | ﹤0.01% | 7629 |
|
|
2025
Q2 | $225 | Buy |
33
+6
| +22% | +$43 | ﹤0.01% | 7819 |
|
|
2025
Q1 | $258 | Buy |
27
+2
| +8% | +$23 | ﹤0.01% | 7639 |
|
|
2024
Q4 | $277 | Sell |
25
-3,298
| -99% | -$42.6K | ﹤0.01% | 7523 |
|
|
2024
Q3 | $60.5K | Sell |
3,323
-4
| -0.1% | -$82 | ﹤0.01% | 6491 |
|
|
2024
Q2 | $94.7K | Buy |
3,327
+17
| +0.5% | +$735 | ﹤0.01% | 6266 |
|
|
2024
Q1 | $168K | Buy |
3,310
+428
| +15% | +$21.6K | ﹤0.01% | 5977 |
|
|
2023
Q4 | $165K | Buy |
2,882
+2,881
| +288,100% | +$136K | ﹤0.01% | 6178 |
|
|
2023
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 7699 |
|
|
2023
Q2 | $11 | Hold |
1
| – | – | ﹤0.01% | 7554 |
|
|
2023
Q1 | $21 | Hold |
1
| – | – | ﹤0.01% | 7572 |
|
|
2022
Q4 | $17 | Hold |
1
| – | – | ﹤0.01% | 8012 |
|
|
2022
Q3 | $0 | Sell |
1
-154
| -99% | -$4.57K | ﹤0.01% | 8198 |
|
|
2022
Q2 | $4K | Buy |
155
+85
| +121% | +$3.3K | ﹤0.01% | 7660 |
|
|
2022
Q1 | $3K | Hold |
70
| – | – | ﹤0.01% | 7995 |
|
|
2021
Q4 | $5K | Hold |
70
| – | – | ﹤0.01% | 7837 |
|
|
2021
Q3 | $13K | Buy |
70
+6
| +9% | +$1.17K | ﹤0.01% | 7508 |
|
|
2021
Q2 | $9K | Buy |
64
+58
| +967% | +$13K | ﹤0.01% | 7323 |
|
|
2021
Q1 | $1K | Buy |
+6
| New | +$2.42K | ﹤0.01% | 7345 |
|
|
2020
Q4 | – | Sell |
-43
| Closed | -$14.9K | – | 7369 |
|
|
2020
Q3 | $14K | Buy |
43
+9
| +26% | +$3.05K | ﹤0.01% | 6367 |
|
|
2020
Q2 | $12K | Sell |
34
-5
| -13% | -$2K | ﹤0.01% | 6393 |
|
|
2020
Q1 | $40K | Buy |
39
+7
| +22% | +$10.2K | ﹤0.01% | 5952 |
|
|
2019
Q4 | $42K | Sell |
32
-3
| -9% | -$4.23K | ﹤0.01% | 6304 |
|
|
2019
Q3 | $48K | Hold |
35
| – | – | ﹤0.01% | 6336 |
|
|
2019
Q2 | $81K | Buy |
+35
| New | +$103K | ﹤0.01% | 6097 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7002 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6997 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7154 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6990 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6986 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6933 |
|
|
2017
Q3 | – | Sell |
-4
| Closed | -$17.1K | – | 6874 |
|
|
2017
Q2 | $18K | Buy |
4
+2
| +100% | +$8.46K | ﹤0.01% | 6262 |
|
|
2017
Q1 | $12K | Sell |
2
-1
| -33% | -$4.66K | ﹤0.01% | 6490 |
|
|
2016
Q4 | $12K | Sell |
3
-6
| -67% | -$74.7K | ﹤0.01% | 6502 |
|
|
2016
Q3 | $197K | Sell |
9
-2
| -18% | -$36.2K | ﹤0.01% | 5135 |
|
|
2016
Q2 | $172K | Buy |
11
+2
| +22% | +$45.7K | ﹤0.01% | 5284 |
|
|
2016
Q1 | $249K | Sell |
9
-2
| -18% | -$42.3K | ﹤0.01% | 5025 |
|
|
2015
Q4 | $305K | Buy |
11
+10
| +1,000% | +$330K | ﹤0.01% | 5110 |
|
|
2015
Q3 | $25K | Sell |
1
-5
| -83% | -$337K | ﹤0.01% | 6244 |
|
|
2015
Q2 | $497K | Buy |
+6
| New | +$550K | ﹤0.01% | 4704 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$133K | – | 6379 |
|
|
2014
Q4 | $71K | Hold |
1
| – | – | ﹤0.01% | 6129 |
|
|
2014
Q3 | $34K | Buy |
+1
| New | +$35.1K | ﹤0.01% | 6766 |
|
|
2014
Q2 | – | Hold |
0
| – | -$1K | – | 8204 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 7648 |
|
|
2013
Q4 | – | Hold |
0
| – | -$2K | – | 8143 |
|
|
2013
Q3 | – | Sell |
-5
| Closed | -$177K | – | 7639 |
|
|
2013
Q2 | $196K | Buy |
+5
| New | +$188K | ﹤0.01% | 5635 |
|
Other funds holding TPST
VVM
VCM
VFT
SM
Bank of America's TPST Position: Q1 2026 in Review
Bank of America sold out of Tempest Therapeutics (TPST) in Q1 2026, closing a stake of 37 shares — an estimated $107 sold.
Bank of America first reported a position in TPST in Q2 2013 and held it in 38 quarters. The position peaked at $497K in Q2 2015. 22 funds tracked by Wall St. Rank hold TPST as of Q1 2026.
- Bank of America reported no remaining Tempest Therapeutics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 37 Tempest Therapeutics shares in Q1 2026, an estimated $107.
- Bank of America first reported a position in Tempest Therapeutics in Q2 2013 and held it in 38 quarters.
- Bank of America's Tempest Therapeutics position peaked at $497K in Q2 2015.
- 22 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.